2026-07-29Bullish
+24.70%weekly changeIQVIA reported Q2 2026 earnings that beat Wall Street consensus estimates and raised its full-year 2026 guidance.
read the report →IQVIA is a leading global provider of advanced analytics, clinical research services, healthcare data technology, and commercial intelligence to the life sciences, pharmaceutical, and healthcare industries.
stitched from the price window carried by each report
IQVIA reported Q2 2026 earnings that beat Wall Street consensus estimates and raised its full-year 2026 guidance.
read the report →IQVIA stock surged after reporting a Q2 earnings beat, record R&D bookings, and raising its full-year 2026 financial guidance.
read the report →